Antirheumatic Agent class drugs

8 results
  • cuprimine

    (penicillamine)
    Bausch Health US, LLC
    CUPRIMINE is indicated for treating Wilson's disease, cystinuria, and severe, active rheumatoid arthritis in patients unresponsive to conventional therapy. It is not effective for ankylosing spondylitis. Treatment aims to reduce copper accumulation in Wilson's disease and urinary cystine levels in cystinuria.
  • depen

    (Penicillamine)
    Meda Pharmaceuticals Inc.
    DEPEN is indicated for treating Wilson’s disease, cystinuria, and severe rheumatoid arthritis in patients who have not responded to conventional therapy. It helps minimize copper intake and promotes copper excretion in Wilson’s disease, reduces cystine excretion to prevent stone formation in cystinuria, and assists in managing severe rheumatoid arthritis.
  • hydroxychloroquine

    (Hydroxychloroquine)
    Chartwell RX, LLC
    Hydroxychloroquine sulfate is indicated for the treatment of uncomplicated malaria, rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in adults and pediatric patients. It also offers malaria prophylaxis in areas without chloroquine resistance. Not recommended for complicated or resistant malaria cases.
  • hydroxychloroquine sulfate

    (Hydroxychloroquine Sulfate)
    Amneal Pharmaceuticals NY LLC
    Hydroxychloroquine sulfate tablets are indicated for treating uncomplicated malaria, rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus. Prophylaxis of malaria is also indicated in areas without chloroquine resistance. It is not recommended for complicated malaria or resistant strains.
  • hydroxychloroquine sulfate

    (HYDROXYCHLOROQUINE SULFATE)
    Dr. Reddy's Laboratories Inc.
    Hydroxychloroquine sulfate is indicated for treating uncomplicated malaria, rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in adults and pediatric patients. It is also used for malaria prophylaxis in areas without chloroquine resistance. Limitations apply to certain malaria strains and treatment scenarios.